nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.231	1	CrCtD
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.206	0.514	CiPCiCtD
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Prednisone—chronic obstructive pulmonary disease	0.194	0.486	CiPCiCtD
Fluocinolone Acetonide—SERPINA6—Prednisolone—chronic obstructive pulmonary disease	0.064	0.524	CbGbCtD
Fluocinolone Acetonide—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0299	0.245	CbGbCtD
Fluocinolone Acetonide—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0282	0.231	CbGbCtD
Fluocinolone Acetonide—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.00595	0.0305	CrCrCtD
Fluocinolone Acetonide—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00523	0.0268	CrCrCtD
Fluocinolone Acetonide—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00523	0.0268	CrCrCtD
Fluocinolone Acetonide—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.00521	0.0267	CrCrCtD
Fluocinolone Acetonide—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00508	0.026	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00506	0.0259	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00494	0.0253	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00493	0.0252	CrCrCtD
Fluocinolone Acetonide—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00493	0.0252	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00481	0.0246	CrCrCtD
Fluocinolone Acetonide—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00481	0.0246	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.0048	0.0246	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0048	0.0246	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.0048	0.0246	CrCrCtD
Fluocinolone Acetonide—Desonide—Prednisone—chronic obstructive pulmonary disease	0.0048	0.0246	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.0048	0.0246	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00468	0.024	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00468	0.024	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00468	0.024	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00468	0.024	CrCrCtD
Fluocinolone Acetonide—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00468	0.024	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00468	0.024	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00457	0.0234	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00457	0.0234	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00446	0.0228	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00446	0.0228	CrCrCtD
Fluocinolone Acetonide—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00446	0.0228	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00446	0.0228	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00446	0.0228	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00436	0.0223	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00436	0.0223	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00436	0.0223	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00435	0.0223	CrCrCtD
Fluocinolone Acetonide—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00435	0.0223	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00435	0.0223	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00435	0.0223	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00425	0.0218	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00425	0.0218	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00425	0.0218	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00417	0.0213	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00408	0.0209	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0208	CrCrCtD
Fluocinolone Acetonide—PLA2G4A—respiratory system—chronic obstructive pulmonary disease	0.000611	0.119	CbGeAlD
Fluocinolone Acetonide—SERPINA6—respiratory system—chronic obstructive pulmonary disease	0.000609	0.119	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—connective tissue—chronic obstructive pulmonary disease	0.000538	0.105	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—bronchus—chronic obstructive pulmonary disease	0.000503	0.0981	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000492	0.096	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—trachea—chronic obstructive pulmonary disease	0.000452	0.0881	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.000371	0.128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—lung—chronic obstructive pulmonary disease	0.000324	0.0633	CbGeAlD
Fluocinolone Acetonide—SERPINA6—lung—chronic obstructive pulmonary disease	0.000323	0.063	CbGeAlD
Fluocinolone Acetonide—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000267	0.052	CbGeAlD
Fluocinolone Acetonide—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000235	0.0458	CbGeAlD
Fluocinolone Acetonide—Herpes simplex—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.0053	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Formoterol—chronic obstructive pulmonary disease	0.000227	0.0053	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00529	CcSEcCtD
Fluocinolone Acetonide—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000219	0.0428	CbGeAlD
Fluocinolone Acetonide—Viral infection—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.0051	CcSEcCtD
Fluocinolone Acetonide—Hypertrichosis—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00505	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.000216	0.00505	CcSEcCtD
Fluocinolone Acetonide—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000215	0.0419	CbGeAlD
Fluocinolone Acetonide—Herpes simplex—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.005	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.000207	0.00484	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00482	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00482	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.000203	0.00475	CcSEcCtD
Fluocinolone Acetonide—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00464	CcSEcCtD
Fluocinolone Acetonide—NR3C1—trachea—chronic obstructive pulmonary disease	0.000197	0.0384	CbGeAlD
Fluocinolone Acetonide—Leukoderma—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00452	CcSEcCtD
Fluocinolone Acetonide—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00448	CcSEcCtD
Fluocinolone Acetonide—Impaired healing—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00444	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00439	CcSEcCtD
Fluocinolone Acetonide—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00437	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000186	0.00435	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000181	0.00423	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00018	0.0042	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.000176	0.00412	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00407	CcSEcCtD
Fluocinolone Acetonide—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.000174	0.00407	CcSEcCtD
Fluocinolone Acetonide—Endophthalmitis—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00403	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.004	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Formoterol—chronic obstructive pulmonary disease	0.000171	0.004	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00392	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00392	CcSEcCtD
Fluocinolone Acetonide—Eczema—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00386	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000162	0.00378	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00377	CcSEcCtD
Fluocinolone Acetonide—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00372	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00363	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00363	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00353	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00351	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00343	CcSEcCtD
Fluocinolone Acetonide—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000146	0.00341	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000144	0.00337	CcSEcCtD
Fluocinolone Acetonide—Abscess—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00334	CcSEcCtD
Fluocinolone Acetonide—NR3C1—lung—chronic obstructive pulmonary disease	0.000142	0.0276	CbGeAlD
Fluocinolone Acetonide—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.00317	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00317	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00317	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000136	0.253	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000136	0.253	CbGdCrCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000134	0.00313	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000133	0.0031	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.0031	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.247	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.247	CbGdCrCtD
Fluocinolone Acetonide—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00306	CcSEcCtD
Fluocinolone Acetonide—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00306	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.00305	CcSEcCtD
Fluocinolone Acetonide—Influenza—Montelukast—chronic obstructive pulmonary disease	0.000128	0.003	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00299	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00298	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000127	0.00296	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00293	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00293	CcSEcCtD
Fluocinolone Acetonide—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00289	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00287	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00285	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00285	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.00285	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.00284	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00279	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—TGFB2—chronic obstructive pulmonary disease	0.000119	0.0412	CbGpPWpGaD
Fluocinolone Acetonide—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000117	0.00274	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00269	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000115	0.00267	CcSEcCtD
Fluocinolone Acetonide—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000115	0.00267	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.00266	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000113	0.00264	CcSEcCtD
Fluocinolone Acetonide—Mania—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00264	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00256	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00256	CcSEcCtD
Fluocinolone Acetonide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00256	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00255	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000108	0.00253	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000108	0.0372	CbGpPWpGaD
Fluocinolone Acetonide—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000107	0.00251	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.00249	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00246	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00246	CcSEcCtD
Fluocinolone Acetonide—Abscess—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00243	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00242	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00241	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00241	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00241	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00236	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00236	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00236	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000101	0.00235	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	9.94e-05	0.00232	CcSEcCtD
Fluocinolone Acetonide—Cough—Tiotropium—chronic obstructive pulmonary disease	9.88e-05	0.00231	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	9.74e-05	0.00227	CcSEcCtD
Fluocinolone Acetonide—Infection—Aminophylline—chronic obstructive pulmonary disease	9.74e-05	0.00227	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	9.72e-05	0.00227	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	9.64e-05	0.00225	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	9.61e-05	0.00224	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	9.46e-05	0.00221	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	9.46e-05	0.00221	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	9.34e-05	0.00218	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	9.27e-05	0.00216	CcSEcCtD
Fluocinolone Acetonide—Rash—Roflumilast—chronic obstructive pulmonary disease	9.27e-05	0.00216	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	9.26e-05	0.00216	CcSEcCtD
Fluocinolone Acetonide—Oedema—Tiotropium—chronic obstructive pulmonary disease	9.24e-05	0.00216	CcSEcCtD
Fluocinolone Acetonide—Headache—Roflumilast—chronic obstructive pulmonary disease	9.21e-05	0.00215	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	9.2e-05	0.00215	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Formoterol—chronic obstructive pulmonary disease	9.2e-05	0.00215	CcSEcCtD
Fluocinolone Acetonide—Infection—Tiotropium—chronic obstructive pulmonary disease	9.18e-05	0.00214	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	9.14e-05	0.00213	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	9.14e-05	0.00213	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Prednisone—chronic obstructive pulmonary disease	9.11e-05	0.00213	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	9.06e-05	0.00212	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	9.06e-05	0.0313	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—PDE4A—chronic obstructive pulmonary disease	9.06e-05	0.0313	CbGpPWpGaD
Fluocinolone Acetonide—Mental disorder—Montelukast—chronic obstructive pulmonary disease	9.01e-05	0.0021	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	8.95e-05	0.00209	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	8.95e-05	0.00209	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.93e-05	0.00209	CcSEcCtD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	8.85e-05	0.317	CrCbGaD
Fluocinolone Acetonide—Back pain—Arformoterol—chronic obstructive pulmonary disease	8.84e-05	0.00206	CcSEcCtD
Fluocinolone Acetonide—Back pain—Formoterol—chronic obstructive pulmonary disease	8.84e-05	0.00206	CcSEcCtD
Fluocinolone Acetonide—Nausea—Roflumilast—chronic obstructive pulmonary disease	8.73e-05	0.00204	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	8.68e-05	0.00203	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	8.67e-05	0.00202	CcSEcCtD
Fluocinolone Acetonide—Cataract—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.00202	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	8.63e-05	0.00201	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MMP14—chronic obstructive pulmonary disease	8.6e-05	0.0297	CbGpPWpGaD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	8.53e-05	0.306	CrCbGaD
Fluocinolone Acetonide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	8.45e-05	0.00197	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	8.42e-05	0.00197	CcSEcCtD
Fluocinolone Acetonide—Back pain—Salbutamol—chronic obstructive pulmonary disease	8.35e-05	0.00195	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	7.98e-05	0.00186	CcSEcCtD
Fluocinolone Acetonide—Cough—Arformoterol—chronic obstructive pulmonary disease	7.98e-05	0.00186	CcSEcCtD
Fluocinolone Acetonide—Cough—Formoterol—chronic obstructive pulmonary disease	7.98e-05	0.00186	CcSEcCtD
Fluocinolone Acetonide—Cough—Montelukast—chronic obstructive pulmonary disease	7.81e-05	0.00182	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	7.78e-05	0.00182	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	7.78e-05	0.00182	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	7.76e-05	0.0269	CbGpPWpGaD
Fluocinolone Acetonide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	7.75e-05	0.00181	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	7.75e-05	0.00181	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	7.62e-05	0.00178	CcSEcCtD
Fluocinolone Acetonide—Cough—Salbutamol—chronic obstructive pulmonary disease	7.53e-05	0.00176	CcSEcCtD
Fluocinolone Acetonide—Oedema—Formoterol—chronic obstructive pulmonary disease	7.46e-05	0.00174	CcSEcCtD
Fluocinolone Acetonide—Oedema—Arformoterol—chronic obstructive pulmonary disease	7.46e-05	0.00174	CcSEcCtD
Fluocinolone Acetonide—Infection—Arformoterol—chronic obstructive pulmonary disease	7.41e-05	0.00173	CcSEcCtD
Fluocinolone Acetonide—Infection—Formoterol—chronic obstructive pulmonary disease	7.41e-05	0.00173	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	7.35e-05	0.00172	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	7.31e-05	0.00171	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	7.31e-05	0.00171	CcSEcCtD
Fluocinolone Acetonide—Oedema—Montelukast—chronic obstructive pulmonary disease	7.31e-05	0.00171	CcSEcCtD
Fluocinolone Acetonide—Infection—Montelukast—chronic obstructive pulmonary disease	7.26e-05	0.00169	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	7.22e-05	0.00169	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—NOS2—chronic obstructive pulmonary disease	7.21e-05	0.258	CrCbGaD
Fluocinolone Acetonide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	7.16e-05	0.00167	CcSEcCtD
Fluocinolone Acetonide—Oedema—Salbutamol—chronic obstructive pulmonary disease	7.04e-05	0.00164	CcSEcCtD
Fluocinolone Acetonide—Infection—Salbutamol—chronic obstructive pulmonary disease	7e-05	0.00163	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	6.93e-05	0.00162	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	6.91e-05	0.00161	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	6.81e-05	0.00159	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	6.8e-05	0.00159	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	6.8e-05	0.00159	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	6.71e-05	0.00157	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	6.68e-05	0.0231	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	6.66e-05	0.00155	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.54e-05	0.00153	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.48e-05	0.00151	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.44e-05	0.0015	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.44e-05	0.0015	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.42e-05	0.0015	CcSEcCtD
Fluocinolone Acetonide—Pain—Arformoterol—chronic obstructive pulmonary disease	6.38e-05	0.00149	CcSEcCtD
Fluocinolone Acetonide—Pain—Formoterol—chronic obstructive pulmonary disease	6.38e-05	0.00149	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.31e-05	0.00147	CcSEcCtD
Fluocinolone Acetonide—Pain—Montelukast—chronic obstructive pulmonary disease	6.25e-05	0.00146	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	6.23e-05	0.00145	CcSEcCtD
Fluocinolone Acetonide—Rash—Aminophylline—chronic obstructive pulmonary disease	6.18e-05	0.00144	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	6.17e-05	0.00144	CcSEcCtD
Fluocinolone Acetonide—Headache—Aminophylline—chronic obstructive pulmonary disease	6.14e-05	0.00143	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	6.11e-05	0.00143	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	6.08e-05	0.00142	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	6.07e-05	0.021	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Salbutamol—chronic obstructive pulmonary disease	6.02e-05	0.00141	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	6.02e-05	0.0208	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	5.9e-05	0.00138	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	5.9e-05	0.00138	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	5.88e-05	0.00137	CcSEcCtD
Fluocinolone Acetonide—Rash—Tiotropium—chronic obstructive pulmonary disease	5.83e-05	0.00136	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	5.82e-05	0.00136	CcSEcCtD
Fluocinolone Acetonide—Nausea—Aminophylline—chronic obstructive pulmonary disease	5.82e-05	0.00136	CcSEcCtD
Fluocinolone Acetonide—Headache—Tiotropium—chronic obstructive pulmonary disease	5.79e-05	0.00135	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	5.78e-05	0.00135	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.64e-05	0.0195	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	5.57e-05	0.0013	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.5e-05	0.00128	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.5e-05	0.00128	CcSEcCtD
Fluocinolone Acetonide—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.49e-05	0.00128	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	5.48e-05	0.00128	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.38e-05	0.00126	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	5.35e-05	0.0185	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.28e-05	0.00123	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.28e-05	0.00123	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	5.19e-05	0.00121	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Montelukast—chronic obstructive pulmonary disease	5.17e-05	0.00121	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	5.1e-05	0.00119	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	5.1e-05	0.00119	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Endothelins—EDN1—chronic obstructive pulmonary disease	5e-05	0.0173	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	5e-05	0.00117	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	4.98e-05	0.00116	CcSEcCtD
Fluocinolone Acetonide—Erythema—Prednisolone—chronic obstructive pulmonary disease	4.95e-05	0.00116	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.93e-05	0.00115	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.93e-05	0.00115	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.83e-05	0.00113	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	4.82e-05	0.00113	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	4.74e-05	0.00111	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Formoterol—chronic obstructive pulmonary disease	4.74e-05	0.00111	CcSEcCtD
Fluocinolone Acetonide—Rash—Arformoterol—chronic obstructive pulmonary disease	4.7e-05	0.0011	CcSEcCtD
Fluocinolone Acetonide—Rash—Formoterol—chronic obstructive pulmonary disease	4.7e-05	0.0011	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.7e-05	0.0011	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.7e-05	0.0011	CcSEcCtD
Fluocinolone Acetonide—Headache—Formoterol—chronic obstructive pulmonary disease	4.67e-05	0.00109	CcSEcCtD
Fluocinolone Acetonide—Headache—Arformoterol—chronic obstructive pulmonary disease	4.67e-05	0.00109	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	4.66e-05	0.00109	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.66e-05	0.00109	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.65e-05	0.00108	CcSEcCtD
Fluocinolone Acetonide—Rash—Montelukast—chronic obstructive pulmonary disease	4.61e-05	0.00108	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.6e-05	0.00107	CcSEcCtD
Fluocinolone Acetonide—Headache—Montelukast—chronic obstructive pulmonary disease	4.58e-05	0.00107	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	4.53e-05	0.0157	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.48e-05	0.00105	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	4.45e-05	0.00104	CcSEcCtD
Fluocinolone Acetonide—Rash—Salbutamol—chronic obstructive pulmonary disease	4.44e-05	0.00104	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.44e-05	0.00104	CcSEcCtD
Fluocinolone Acetonide—Nausea—Formoterol—chronic obstructive pulmonary disease	4.43e-05	0.00103	CcSEcCtD
Fluocinolone Acetonide—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.43e-05	0.00103	CcSEcCtD
Fluocinolone Acetonide—Headache—Salbutamol—chronic obstructive pulmonary disease	4.41e-05	0.00103	CcSEcCtD
Fluocinolone Acetonide—Nausea—Montelukast—chronic obstructive pulmonary disease	4.34e-05	0.00101	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Endothelins—MMP1—chronic obstructive pulmonary disease	4.2e-05	0.0145	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.18e-05	0.000977	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	4.06e-05	0.000948	CcSEcCtD
Fluocinolone Acetonide—Oedema—Prednisolone—chronic obstructive pulmonary disease	4.04e-05	0.000943	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	3.86e-05	0.000902	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	3.78e-05	0.0131	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	3.74e-05	0.0129	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—NOS2—chronic obstructive pulmonary disease	3.65e-05	0.0126	CbGpPWpGaD
Fluocinolone Acetonide—Alopecia—Prednisone—chronic obstructive pulmonary disease	3.65e-05	0.000852	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	3.62e-05	0.000845	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.6e-05	0.00084	CcSEcCtD
Fluocinolone Acetonide—Erythema—Prednisone—chronic obstructive pulmonary disease	3.6e-05	0.00084	CcSEcCtD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	3.46e-05	0.012	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Prednisolone—chronic obstructive pulmonary disease	3.45e-05	0.000807	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	3.39e-05	0.000791	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	3.31e-05	0.119	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	3.25e-05	0.0113	CbGpPWpGaD
Fluocinolone Acetonide—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.000754	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	3.22e-05	0.0111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	3.2e-05	0.0111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	3.16e-05	0.0109	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	3.09e-05	0.0107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	3.07e-05	0.0106	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.06e-05	0.000715	CcSEcCtD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	3e-05	0.0104	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	2.98e-05	0.000695	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	2.94e-05	0.0102	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Prednisone—chronic obstructive pulmonary disease	2.94e-05	0.000685	CcSEcCtD
Fluocinolone Acetonide—Infection—Prednisone—chronic obstructive pulmonary disease	2.92e-05	0.000681	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	2.88e-05	0.000672	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	2.86e-05	0.0099	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	2.76e-05	0.00955	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	2.73e-05	0.00946	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	2.71e-05	0.00937	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	2.68e-05	0.00929	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000624	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.67e-05	0.000624	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	2.67e-05	0.00922	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	2.66e-05	0.00919	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	2.6e-05	0.00898	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	2.57e-05	0.00889	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Prednisolone—chronic obstructive pulmonary disease	2.55e-05	0.000595	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.54e-05	0.000594	CcSEcCtD
Fluocinolone Acetonide—Headache—Prednisolone—chronic obstructive pulmonary disease	2.53e-05	0.000591	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	2.52e-05	0.00871	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	2.49e-05	0.00863	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	2.44e-05	0.00846	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.44e-05	0.00845	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	2.41e-05	0.00834	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.4e-05	0.00056	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	2.36e-05	0.00815	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.32e-05	0.000542	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.16e-05	0.000505	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.08e-05	0.000485	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.01e-05	0.000469	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.94e-05	0.000453	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	1.9e-05	0.00659	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.87e-05	0.000436	CcSEcCtD
Fluocinolone Acetonide—Rash—Prednisone—chronic obstructive pulmonary disease	1.85e-05	0.000432	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.85e-05	0.000432	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	1.85e-05	0.00639	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Prednisone—chronic obstructive pulmonary disease	1.84e-05	0.000429	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.00608	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Prednisone—chronic obstructive pulmonary disease	1.74e-05	0.000407	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.69e-05	0.00586	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APIP—chronic obstructive pulmonary disease	1.69e-05	0.00584	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.61e-05	0.00558	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.59e-05	0.0055	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	1.58e-05	0.00548	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.55e-05	0.00536	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.54e-05	0.00534	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.5e-05	0.00519	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	1.37e-05	0.00475	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.00464	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.31e-05	0.00454	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.27e-05	0.00438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.23e-05	0.00426	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.00417	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.2e-05	0.00415	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.17e-05	0.00405	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	1.17e-05	0.00404	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.12e-05	0.00387	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.11e-05	0.00384	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.11e-05	0.00384	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GC—chronic obstructive pulmonary disease	1.09e-05	0.00377	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.08e-05	0.00373	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.00351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.01e-05	0.0035	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	9.88e-06	0.00342	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.67e-06	0.00335	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	9.51e-06	0.00329	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.35e-06	0.00324	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.26e-06	0.0032	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.04e-06	0.00313	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.89e-06	0.00307	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	8.7e-06	0.00301	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.3e-06	0.00287	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.14e-06	0.00282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.06e-06	0.00279	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	8.05e-06	0.00278	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	7.99e-06	0.00276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MMP1—chronic obstructive pulmonary disease	7.94e-06	0.00275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAU—chronic obstructive pulmonary disease	7.8e-06	0.0027	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.75e-06	0.00268	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.52e-06	0.0026	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	7.46e-06	0.00258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	7.39e-06	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS2—chronic obstructive pulmonary disease	7.16e-06	0.00248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.09e-06	0.00245	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.83e-06	0.00236	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.45e-06	0.00223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.07e-06	0.0021	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	6.03e-06	0.00209	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.02e-06	0.00208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—chronic obstructive pulmonary disease	6.02e-06	0.00208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.94e-06	0.00206	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCLC—chronic obstructive pulmonary disease	5.88e-06	0.00203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—chronic obstructive pulmonary disease	5.76e-06	0.00199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.71e-06	0.00198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.48e-06	0.0019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.42e-06	0.00188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CTGF—chronic obstructive pulmonary disease	5.36e-06	0.00186	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.2e-06	0.0018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.94e-06	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.88e-06	0.00169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.74e-06	0.00164	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	4.62e-06	0.0016	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.55e-06	0.00157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.18e-06	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.15e-06	0.00144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.12e-06	0.00143	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.06e-06	0.00141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.88e-06	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.81e-06	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.79e-06	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.59e-06	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.58e-06	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.2e-06	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—chronic obstructive pulmonary disease	3.13e-06	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.93e-06	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.91e-06	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.8e-06	0.00097	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.61e-06	0.000901	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—chronic obstructive pulmonary disease	2.44e-06	0.000844	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.33e-06	0.000808	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.22e-06	0.00077	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.14e-06	0.000741	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.04e-06	0.000707	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.95e-06	0.000675	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.73e-06	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.65e-06	0.00057	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.57e-06	0.000542	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.41e-06	0.000486	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.29e-06	0.000447	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.27e-06	0.000438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.06e-06	0.000368	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.72e-07	0.000336	CbGpPWpGaD
